Biological impact of chemotherapy during treatment with EGFR tyrosine kinase inhibitors for non-small cell lung cancer positive for EGFR activating mutationsEiji Iwama, Isamu Okamoto, Taishi Harada et al.|Lung Cancer|2025Cited by 3